Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma.

MLA

Jhawar, Sachin R., et al. “Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma.” JAMA Oncology, vol. 5, no. 5, May 2019, pp. 689–95. EBSCOhost, https://doi.org/10.1001/jamaoncol.2018.5911.

APA

Jhawar, S. R., Rivera-Núñez, Z., Drachtman, R., Cole, P. D., Hoppe, B. S., & Parikh, R. R. (2019). Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma. JAMA Oncology, 5(5), 689–695. https://doi.org/10.1001/jamaoncol.2018.5911

Chicago

Jhawar, Sachin R, Zorimar Rivera-Núñez, Richard Drachtman, Peter D Cole, Bradford S Hoppe, and Rahul R Parikh. 2019. “Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma.” JAMA Oncology 5 (5): 689–95. doi:10.1001/jamaoncol.2018.5911.